retatrutide new england journal of medicine Is the future? Health new england journal of medicine

After the FDA declared GLP-1 shortages resolved in early 2025 and began cracking down on compounding pharmacies, Ro and Hims & Hers shifted to partnering with Eli Lilly and Novo Nordisk's direct-to-consumer cash-pay pharmacies, LillyDirect (launched January 2024) and NovoCare (launched March 2025), that the manufacturers had built to bypass insurance and PBM channels and capture the unprecedented consumer demand around by GLP-1s, for which ~60% of patients are denied coverage by their insurers

Gonadotropin-releasing hormone (GnRH) drives luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release

Press, Cold Spring Harbor, 1998)

Most of the patients who desperately seek fair complexion or a new treatment modality for their refractory facial melanosis are typically internet and social media savvy